Aerie Pharmaceuticals - Positive Rhopressa Launch May Mark The Stock Price Peak (NASDAQ:AERI) | Seeking Alpha
Aerie adds Vargas, once of Abbott, to medical affairs team | Fierce Biotech
Aerie swoops on DSM tech for eye disease candidates | Fierce Biotech
Tiny Aerie ready to double its staff to roll out now-FDA-approved Rhopressa | Fierce Pharma
U.S. biotech opening plant in Ireland after issues with CMO delay glaucoma drug | Fierce Pharma
Forum 2021 | How to Create the Perfect Omni Channel Marketing Strategy in 5 Steps - YouTube
VaynerMedia Wins American Eagle Media Business 02/25/2021
Electrical Grid Parts Shortages Are Slowing Truck-Charging Projects - WSJ
Ophthalmology Technology Forum Agenda • Octane
Aerie raids Alcon again, returning this time with an R&D VP | Fierce Biotech
ESCRS - Aerie in Europe
David O'Keeffe - Finance Manager - Aerie Pharmaceuticals | LinkedIn
Macuject to Present at Ophthalmology Futures Forum
The Top Line': Genentech diversity miss, diabetes brand recall
American Eagle Enters Resale, Using AR On Snap 04/17/2023
Electrical Grid Parts Shortages Are Slowing Truck-Charging Projects - WSJ
Aerie Pharma shares soar as FDA lowers the hurdle for PhIII | Fierce Biotech
Aerie Pharma Seeks FDA Nod to Sell Ireland-based Product in US | INN
ESFRI Stakeholders Forum Meetup in Tenerife on Research Infrastructures | canSERV posted on the topic | LinkedIn
Aerie CEO exits days after downplaying midphase eye disease flop | Fierce Biotech
Past forums – OPHTHALMOLOGY FUTURES FORUMS
Aerie: A Brilliant Future, Derisking In Progress, And The Making Of A Major Ophthalmic Pharmaceutical (NASDAQ:AERI) | Seeking Alpha
Nikos Aridas on LinkedIn: Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening…
Aerie: A Brilliant Future, Derisking In Progress, And The Making Of A Major Ophthalmic Pharmaceutical (NASDAQ:AERI) | Seeking Alpha
